Michael L Levitz - EVP, Anika Therapeutics, Inc

As of August 13, 2021


Michael L Levitz Net Worth

  • Net worth is estimated to be at least $20.53M
  • Owns at least 7,486 units of Anika Therapeutics, Inc stock

Michael L Levitz Compensation at Anika Therapeutics, Inc in 2020

  • Earned a $173,077 salary and a $73 bonus
  • Received a total compensation of $1,857,960

Michael L Levitz Trading

  • Largest purchase of shares was 3,627 units , worth over $145.83K on August 13, 2021
  • In total has made about 4 transactions over a year
  • Usually trades in August, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Michael L Levitz Mailing Address

  • Mailing address is C/o Analogic Corporation 8 Centennial Drive Peabody MA 01960 MA

Anika Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Compensation
Total
Cheryl R. Blanchard, Ph.D. 2020 $548,077 $458,510 $5,335,439 $3,659,450 $27,958 $10,029,434
Michael L. Levitz 2020 $173,077 $73,601 $799,971 $799,993 $11,318 $1,857,960
David Colleran 2020 $344,077 $143,931 $645,900 $553,445 $18,263 $1,705,616
Thomas Finnerty 2020 $353,505 $143,169 $626,367 - $20,746 $1,143,787
James Loerop 2020 $381,563 $171,703 $464,449 - $22,156 $1,039,871
Joseph G. Darling 2020 $80,752 - - - $208,001 $288,753
Sylvia Cheung 2020 $294,252 - $924,637 - $89,644 $1,308,534
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/898437/000117184321002976/def14a_042921.htm

Anika Therapeutics, Inc Insider Trading

  • The most recent transaction was 3,627 units bought on August 13, 2021 by Michael L Levitz worth over $145.83K
  • In the last 17 years, insiders at Anika Therapeutics, Inc sold an estimated value of $66.33M and bought an estimated value of $5.39M
  • The most active traders are Charles H Sherwood, CEO and Director,  Steve Wheeler, Director,  and Joseph L Bower, Director
  • Insider trading is most common in February and January, with the busiest year in 2006 and 2017

Anika Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1